Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1464-1472

  Felli, Nadia ^a   Pedini, Francesca ^a   Zeuner, Ann ^a,b   Petrucci, Eleonora ^a   Testa, Ugo ^a   Conticello, Concerta ^b   Biffoni, Mauro ^a   Di Cataldo, Andrea ^c   Winkles, Jeffrey A ^d   Peschle, Cesare ^a   De Maria, Ruggero ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b IOM Foundation   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE; FAS LIGAND; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; FIBROBLAST GROWTH FACTOR INDUCIBLE 14 ANTIBODY; GAMMA INTERFERON; PROTEIN; RECEPTOR; RECOMBINANT PROTEIN; RECOMBINANT TWEAK PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TWEAK PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GROWTH INHIBITION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR BINDING;

EID: 22544451527     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1464     Document Type: Article

References (47)

1. Gregory, C. J., and A. C. Eaves. 1978. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 51: 527-537.
2. Kelley, L. L., M. J. Koury, M. C. Bondurant, S. T. Koury, S. T. Sawyer, and A. Wickrema. 1993. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82: 2340-2352.
3. Dolznig, H., B. Habermann, K. Stangl, E. M. Deiner, R. Moriggl, H. Beug, and E. W. Mullner. 2002. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr. Biol. 12: 1076-1085.
4. Silva, M., D. Grillot, A. Benito, C. Richard, G. Nunez, and J. L. Fernandez-Luna. 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88: 1576-1582.
5. De Maria, R., U. Testa, L. Luchetti, A. Zeuner, G. Stassi, E. Pelosi, R. Riccioni, N. Felli, P. Samoggia, and C. Peschle. 1999. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 93: 796-803.
6. De Maria, R., A. Zeuner, A. Eramo, C. Domenichelli, D. Bonci, F. Grignani, S. M. Srinivasula, E. S. Alnemri, U. Testa, and C. Peschle. 1999. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-493.
7. Zamai, L., P. Secchiero, S. Pierpaoli, A. Bassini, S. Papa, E. S. Alnemri, L. Guidotti, M. Vitale, and G. Zauli. 2000. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95: 3716-3724.
8. Rusten, L. S., and S. E. Jacobsen. 1995. Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood 85: 989-996.
9. + highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood 99: 1305-1313.
10. Zeuner, A., Eramo, A., Testa, U., Felli, N., Pelosi, E., Mariani, G., Srinivasula, S.M., Alnemri, E.S., Condorelli, G., Peschle, C., De Maria, R. 2003. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1. Cell Death Differ. 10: 905-913.
11. Sui, X., S. B. Krantz, and Z. J. Zhao. 2000. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Eur. J. Haematol. 110: 63-70.
12. Ohneda, O., N. Yanai, and M. Obinata. 1992. Combined action of c-kit and erythropoietin on erythroid progenitor cells. Development 114: 245-252.
13. Selleri, C., J. P. Maciejewski, T. Sato, and N. S. Young. 1996. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87: 4149-4157.
14. Dai, C. H., J. O. Price, T. Brunner, and S. B. Krantz. 1998. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood 91: 1235-1242.
15. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85: 3183-3190.
16. Zoumbos, N. C., P. Gascon, J. Y. Djeu, and N. S. Young. 1985. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc. Natl. Acad. Sci. USA 82: 188-192.
17. Chicheportiche, Y., P. R. Bourdon, H. Xu, Y. M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401-32410.
18. Wiley, S. R., and J. A. Winkles. 2003. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev. 14: 241-249.
19. Marsters, S. A., J. P. Sheridan, R. M. Pitti, J. Brush, A. Goddard, and A. Ashkenazi. 1998. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8: 525-528.
20. Lynch, C. N., Y. C. Wang, J. K. Lund, Y. W. Chen, J. A. Leal, and S. R. Wiley. 1999. TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 274: 8455-8459.
21. Jakubowski, A., B. Browning, M. Lukashev, I. Sizing, J. S. Thompson, C. D. Benjamin, Y. M. Hsu, C. Ambrose, T. S. Zheng, and L. C. Burkly. 2002. Dual role for TWEAK in angiogenic regulation. J. Cell Sci. 115: 267-274.
22. Donohue, P. J., C. M. Richards, S. A. Brown, H. N. Hanscom, J. Buschman, S. Thangada, T. Hla, M. S. Williams, and J. A. Winkles. 2003. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler. Thromb. Vasc. Biol. 23: 594-600.
23. Harada, N., M. Nakayama, H. Nakano, Y. Fukuchi, H. Yagita, and K. Okumura. 2002. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem. Biophys. Kes. Commun. 299: 488-493.
24. Nakayama, M., N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita. 2000. Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity. J. Exp. Med. 192: 1373-1380.
25. Kaptein, A., M. Jansen, G. Dilaver, J. Kitson, L. Dash, E. Wang, M. J. Owen, J. L. Bodmer, J. Tschopp, and S. N. Farrow. 2000. Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3). FEBS Lett. 485: 135-141.
26. Nakayama, M., K. Ishidoh, N. Kayagaki, Y. Kojima, N. Yamaguchi, H. Nakano, E. Kominami, K. Okumura, and H. Yagita. 2002. Multiple pathways of TWEAK-induced cell death. J. Immunol. 168: 734-743.
27. Wiley, S. R., L. Cassiano, T. Lofton, T. Davis-Smith, J. A. Winkles, V. Lindner, H. Liu, T. O. Daniel, C. A. Smith, and W. C. Fanslow. 2001. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15: 837-846.
28. Meighan-Mantha, R. L., D. K. Hsu, Y. Guo, S. A. Brown, S. L. Feng, K. A. Peifley, G. F. Alberts, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, et al. 1999. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274: 33166-33176.
29. Brown, S. A., C. M. Richards, H. N. Hanscom, S. L. Feng, and J. A. Winkles. 2003. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor- associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem. J. 371: 395-403.
30. Han, S., K. Yoon, K. Lee, K. Kim, H. Jang, N. K. Lee, K. Hwang, and S. Young Lee. 2003. TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-κB through TNF receptor-associated factors. Biochem. Biophys. Res. Commun. 305: 789-796.
31. Nakayama, M., K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, K. Okumura, and H. Yagita. 2003. Fibroblast growth factor-indudble 14 mediates multiple pathways of TWEAK-induced cell death. J. Immunol. 170: 341-348.
32. Gabbianelli, M., M. Sargiacomo, E. Pelosi, U. Testa, G. Isacchi, and C. Peschle. 1990. "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 249: 1561-1564.
33. Ziegler, B., U. Testa, G. Condorelli, L. Vitelli, M. Valtieri, and C. Peschle. 1998. Unilineage hematopoietic differentiation in bulk and single cell culture. Stem. Cells 16(Suppl. 1): 51-73.
34. Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56: 121-111.
35. Dai, C., and S. B. Krantz. 1999. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93: 3309-3316.
36. Secchiero, P., E. Melloni, M. Heikinheimo, S. Mannisto, R. Di Pietro, A. Iacone, and G. Zauli. 2004. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 103: 517-522.
37. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
38. Domen, J. 2000. The role of apoptosis in regulating hematopoiesis and hematopoietic stem cells. Immunol. Res. 22: 83-94.
39. Schneider, E., G. Moreau, A. Arnould, F. Vasseur, N. Khodabaccus, M. Dy, and S. Ezine. 1999. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood 94: 2613-2621.
40. Long, Q., H. Huang, E. Shafizadeh, N. Liu, and S. Lin. 2000. Stimulation of erythropoiesis by inhibiting a new hematopoietic death receptor in transgenic zebrafish. Nat. Cell Biol. 2: 549-552.
41. Yeh, W. C., J. L. Pompa, M. E. McCurrach, H. B. Shu, A. J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958.
42. Varfolomeev, E. E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, et al. 1998. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276.
43. Desplat-Jego, S., S. Varriale, R. Creidy, R. Terra, D. Bernard, M. Khrestchatisky, S. Izui, Y. Chicheportiche, and J. Boucraut. 2002. TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J. Neuroimmunol. 133: 116-123.
44. Tran, N. L., W. S. McDonough, B. A. Savitch, T. F. Sawyer, J. A. Winkles, and M. E. Berens. 2005. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NfκB pathway activation and BCL-XL/BCL-W expression. J. Biol. Chem. 280: 3483-3492.
45. Feng, S. L., Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles. 2000. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am. J. Pathol. 156: 1253-1261.
46. Rathbun, R. K., G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al. 1997. Inactivation of the Fanconi anemia group C gene augments interferon-γ- induced apoptotic responses in hematopoietic cells. Blood 90: 974-985.
47. Dufour, C., A. Corcione, J. Svahn, R. Haupt, V. Poggi, A. Nandor Bekassy, R. Scime, A. Pistorio, and V. Pistoia. 2003. TNF-α and IFN-γ are over expressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro. Blood 102: 2053-2059.